Skip to main content

CASE REPORT article

Front. Surg.
Sec. Vascular Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1477926

Accidental Intra-arterial Injection of Enoxaparin Sodium Leading to Abdominal Wall Expanding Subcutaneous Hematoma and Abdominal Wound: Case Report-Vascular

Provisionally accepted
  • 1 University College, University of Toledo, Toledo, Ohio, United States
  • 2 University of Toledo Medical Center, Toledo, United States
  • 3 Jobst Vascular Institute, Toledo, Ohio, United States

The final, formatted version of the article will be published soon.

    Introduction: Enoxaparin sodium (Lovenox ®) is a commonly used anticoagulant medication that is self-administered via subcutaneous injection to prevent the formation of pathologic blood clots. It is used as a bridge to long-term anticoagulation with warfarin in patients at high risk for thromboembolic events. It is generally well-tolerated and has a favorable safety profile. The most common injection site reactions caused by enoxaparin sodium are urticaria, ecchymosis, and skin and fat necrosis. Case Report: A 56 year-old female with extensive thromboembolic history was completing an enoxaparin sodium bridge to warfarin when she accidentally self-injected enoxaparin sodium into the left superficial epigastric artery, resulting in the formation of a large expanding hematoma and the development of hemorrhagic shock. Controlling the bleeding required reversal of anticoagulation, transfusion, and coil embolization of the affected arteries. Surgical evacuation of the hematoma was performed, and the resultant wound was managed postoperatively with negative pressure wound therapy (NPWT) for one month. After discontinuation of NPWT, the wound was allowed to heal by secondary intention using dressing changes. Conclusions: The findings of this case report suggest that NPWT followed by conventional dressings can be used to close and heal the wound created by surgical hematoma evacuation.

    Keywords: Lovenox, subcutaneous hematoma, Anticoagulant, Negative pressure wound therapy, bleeding, Intra-arterial injection

    Received: 08 Aug 2024; Accepted: 03 Jan 2025.

    Copyright: © 2025 Howell and Simman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Richard Simman, University of Toledo Medical Center, Toledo, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.